EP Patent

EP4382529A1 — A process for preparing pure (3s)-pyrrolidin-3-ol and pure (3s)-pyrrolidin-3-ol hydrochloride

Assigned to Bayer Consumer Care AG · Expires 2024-06-12 · 2y expired

What this patent protects

The present invention relates to a process for preparing of pure (3S)-Pyrrolidin-3-ol ("the base") of formula (I) and the preparation of the corresponding (3S)-Pyrrolidin-3-ol hydrochloride ("the hydrochloride") of formula (II)

USPTO Abstract

The present invention relates to a process for preparing of pure (3S)-Pyrrolidin-3-ol ("the base") of formula (I) and the preparation of the corresponding (3S)-Pyrrolidin-3-ol hydrochloride ("the hydrochloride") of formula (II)

Drugs covered by this patent

larotrectinib-sulfate (LAROTRECTINIB SULFATE)

Patent Metadata

Patent number: EP4382529A1
Jurisdiction: EP
Classification: —
Expires: 2024-06-12
Drug substance claim: No
Drug product claim: No
Assignee: Bayer Consumer Care AG
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.